Status:

COMPLETED

A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial

Lead Sponsor:

Lipocine Inc.

Conditions:

NASH - Nonalcoholic Steatohepatitis

Eligibility:

MALE

18-80 years

Phase:

PHASE2

Brief Summary

This is an open-label extension to Study LPCN 1144-18-002. The study is aimed at evaluating the safety and tolerability of LPCN 1144 in adult men with NASH.

Detailed Description

This is a multicenter, open-label extension protocol to provide LPCN 1144, an investigational drug, to subjects with NASH who have completed the LPCN 1144-18-002 protocol. Enrolled subjects will be gi...

Eligibility Criteria

Inclusion

  • Subjects who have completed the 38 week study LPCN 1144-18-002 and wish to be treated with LPCN 1144
  • Subject must sign the Informed Consent Form to participate in the study

Exclusion

  • Has participated or is participating in any other clinical (investigational) study after completion of LPCN 1144-18-002 study
  • Subjects who are currently receiving any androgens or estrogens
  • Subjects who are not willing to use adequate contraception for the duration of the study
  • Use of drugs historically associated with NAFLD (amiodarone, methotrexate, systemic glucocorticoids, tetracyclines, tamoxifen, estrogens, anabolic steroids, valproic acid, other known hepatotoxins) for more than 2 weeks in the 2 years prior to enrollment
  • Any other condition, which in the opinion of the investigator would impede compliance or hinder completion of the study

Key Trial Info

Start Date :

November 11 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2022

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT04685993

Start Date

November 11 2020

End Date

March 1 2022

Last Update

July 17 2024

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Clinical Trials Research

Roseville, California, United States, 95661

2

Sensible Healthcare, LLC

Ocoee, Florida, United States, 34761

3

Jubilee Clinical Research, Inc.

Las Vegas, Nevada, United States, 89106

4

R&H Clinical Research

Katy, Texas, United States, 77494